Axiom · 1 week ago
IP & Software Licensing Counsel – High-Tech, Biotech & Industrial Focus
Axiom is transforming the legal services landscape by delivering innovative solutions. They are seeking an IP & Software Licensing Counsel with experience in technology and software licensing to support innovation-driven companies in various industries such as biotech and high-tech.
ComplianceConsultingLaw EnforcementLegalProfessional Services
Responsibilities
Draft, review, and negotiate technology, software, and IP licensing agreements, including SaaS, cloud, and standards-based licenses
Support clients on IP strategy, software compliance, open-source licensing, and commercial contract matters
Assist with IP portfolio management, license audits, royalty tracking, and monetization initiatives
Collaborate with engineering, product, and business teams to align licensing strategy with technology development and commercialization goals
Support cross-border or multi-jurisdictional licensing projects when needed
Qualification
Required
JD or equivalent, with active U.S. bar membership in good standing
2–7 years of experience in technology, software, or IP licensing
Experience working with biotech, industrial, automotive, or high-tech companies, including familiarity with SaaS, cloud, or AI/data science technologies
Strong drafting, negotiation, and analytical skills
Ability to collaborate with cross-functional teams in fast-paced, product-focused environments
Preferred
Prior experience at Danaher, Medtronic, GE, Accenture, or other innovation-driven industrial/tech firms
Exposure to AI, data science, connected devices, or software licensing ecosystems
Familiarity with patent, copyright, and trade secret issues in tech-driven businesses
Willingness to support remote or onsite client engagements in U.S. locations
Benefits
Health benefits
401k
Professional development tools and resources
Learning and development programs
Company
Axiom
Axiom is where high-caliber legal talent meets full-service law firm work.
Funding
Current Stage
Late StageTotal Funding
$28MKey Investors
Permira
2019-09-06Corporate Round
2013-02-06Series Unknown· $28M
Recent News
2025-08-26
Company data provided by crunchbase